Japan share market finished lower for third straight session on Tuesday, 14 June 2022, on tracking negative lead from Wall Street overnight amid lingering concerns about inflation and the outlook for interest rates. Meanwhile, concerns about supply disruption due to the re-imposition of restrictions in Beijing, Shanghai and other places also weighed down sentiments. At closing bell, the 225-issue Nikkei Stock Average stumbled by 357.58 […]
Japan share market finished lower for third straight session on Tuesday, 14 June 2022, on tracking negative lead from Wall Street overnight amid lingering concerns about inflation and the outlook for interest rates. Meanwhile, concerns about supply disruption due to the re-imposition of restrictions in Beijing, Shanghai and other places also weighed down sentiments. At closing bell, the 225-issue Nikkei Stock Average stumbled by 357.58 […]
Japan share market finished lower for third straight session on Tuesday, 14 June 2022, on tracking negative lead from Wall Street overnight amid lingering concerns about inflation and the outlook for interest rates. Meanwhile, concerns about supply disruption due to the re-imposition of restrictions in Beijing, Shanghai and other places also weighed down sentiments. At closing bell, the 225-issue Nikkei Stock Average stumbled by 357.58 […]
Japan share market finished lower for third straight session on Tuesday, 14 June 2022, on tracking negative lead from Wall Street overnight amid lingering concerns about inflation and the outlook for interest rates. Meanwhile, concerns about supply disruption due to the re-imposition of restrictions in Beijing, Shanghai and other places also weighed down sentiments. At closing bell, the 225-issue Nikkei Stock Average stumbled by 357.58 […]
The drug major received South African Health Products Regulatory Authority (SAHPRA) approval to launch 4-in-1 fixed-dose combination of four antiretroviral (ARV) treatments for infants and young children with HIV in South Africa.
The drug major received South African Health Products Regulatory Authority (SAHPRA) approval to launch 4-in-1 fixed-dose combination of four antiretroviral (ARV) treatments for infants and young children with HIV in South Africa.
Sales decline 77.78% to Rs 0.02 crore
Sales decline 77.78% to Rs 0.02 crore
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
